The Latest
Why expanding the TRIPS waiver won’t improve access to COVID-19 treatments
November 29, 2022IP has enabled the development of life-saving vaccines and treatments, yet some want to further waive protections for COVID-19 innovation under TRIPS. Our recent blog dives into why this won’t address the true barriers to treatment access and the real challenges on which policy makers need to focus.
